2012-09-19 16:33:26 - Genmab A/S - Company Profile - a new company profile report on companiesandmarkets.com

Genmab A/S - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company´s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features

- Detailed information on Genmab A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Genmab A/S in the form of a SWOT analysis
- An in-depth view of the business model of Genmab A/S including a breakdown and examination of key business segments
- Intelligence on Genmab A/S´s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Genmab A/S, such as business expansion, restructuring,

 

 

and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights

Genmab is a biotechnology company engaged in the discovery and development of human antibodies for the treatment of life-threatening and debilitating diseases. The company´s therapeutic emphasis is on the areas of cancer, infectious disease, rheumatoid arthritis and other inflammatory conditions. It is headquartered in Copenhagen, Denmark and employed 189 people as of December 31, 2010. The company recorded revenues of DKK582.1 million ($103.7 million*) during the financial year (FY) ended December 2010, a decrease of 0.7% over FY2009. The operating loss of the company was DKK160.7 million ($28.6 million*) during FY2010, as compared to an operating loss of DKK498 million ($88.7 million*) in FY2009. The net loss was DKK321.5 million ($57.3 million*) in FY2010, as compared to a net loss of DKK1,010.8 million ($180 million*) FY2009. * Calculated using the constant conversion rate of DKK1 = $0.1781 for the financial year ended December 31, 2010.

Reasons to Purchase

- Gain understanding of Genmab A/S and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Genmab A/S as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers´ businesses better
- Stay up to date on Genmab A/S´s business structure, strategy and prospects

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.